-
#ASH2019 Demuestran por primera vez la supervivencia a largo plazo de las terapias CAR-T#hematologiahttps://www.elmundo.es/ciencia-y-salud/salud/2019/12/11/5defeef8fdddff3f278b4660.html … -
For those at
#ASH2019, here's a recent article about the great target that BCMA seems to be: https://go.nature.com/38qVTpe#ASH19pic.twitter.com/5BTcwsC5GH
-
For those interested in developments at
#ASH2019, here's a collection of reviews on therapeutic strategies for sickle cell disease https://rdcu.be/bYEtM , innovations in haemophilia treatment https://rdcu.be/bYEtQ and gene therapies targeting HSCs https://rdcu.be/bYEt5 pic.twitter.com/gj0ZqJxqQD
-
Living with cancer is a reality for many chronic
#leukaemia patients. More focus needed on the ongoing issues of living with chronic cancer such as cancer related fatigue which can be debilitating#spotleukaemia#ASH2019 https://news.sky.com/story/majority-of-public-think-cancer-sufferers-cannot-live-for-years-institute-of-cancer-research-survey-11882032?dcmp=snt-sf-twitter&utm_source=t.co&utm_medium=referral … -
.
@bluebirdbio's presents very encouraging#SickleCell#genetherapy at#ASH19 - https://www.bloomberg.com/news/articles/2019-12-07/bluebird-sickle-cell-gene-therapy-ends-painful-attacks-for-some …#ASH2019#ASH#ChronicPain#chronicdiseasePrikaži ovu nit -
"Letting academic medical centers make CAR-T drugs would save billions." https://www.statnews.com/2019/11/20/car-t-drugs-academic-medical-centers-save-billions/comment-page-2/ … via
@statnews#MarketAccess#ASH19#ASH2019 -
$CYCC - Significant Upside With Recent Multi-Million Alliance With MD Anderson And Upcoming Data Release => https://seekingalpha.com/instablog/50857529-johnsoriaknows/5381271-cycc-significant-upside-recent-multi-million-alliance-md-anderson-and-upcoming-data-release …#Cyclacel#Biotechnology#BioTech#ASH2019#Stock#CYCC
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.